Danaher Co. (NYSE:DHR) has received an average recommendation of “Buy” from the twenty-two ratings firms that are covering the stock, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, five have assigned a hold recommendation, fifteen have given a buy recommendation and one has issued a strong buy recommendation on the company. The average 12-month price objective among brokerages that have updated their coverage on the stock in the last year is $101.74.
DHR has been the subject of several recent research reports. Argus boosted their price target on Danaher from $100.00 to $115.00 and gave the stock a “buy” rating in a research report on Thursday, February 1st. Cowen reissued a “buy” rating and issued a $110.00 price target on shares of Danaher in a research report on Tuesday, January 30th. Robert W. Baird reissued a “buy” rating and issued a $99.00 price target on shares of Danaher in a research report on Friday, December 15th. Citigroup boosted their price target on Danaher to $107.00 and gave the stock a “buy” rating in a research report on Friday, December 15th. Finally, Barclays initiated coverage on Danaher in a research report on Thursday, February 15th. They issued an “overweight” rating and a $110.00 price target for the company.
In other Danaher news, CFO Daniel L. Comas sold 62,989 shares of the business’s stock in a transaction dated Thursday, February 1st. The stock was sold at an average price of $101.96, for a total transaction of $6,422,358.44. Following the sale, the chief financial officer now owns 227,805 shares in the company, valued at approximately $23,226,997.80. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Rainer Blair sold 51,080 shares of the business’s stock in a transaction dated Wednesday, February 21st. The shares were sold at an average price of $97.26, for a total value of $4,968,040.80. Following the sale, the insider now owns 50,477 shares in the company, valued at approximately $4,909,393.02. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 288,123 shares of company stock worth $29,162,927. 12.20% of the stock is owned by company insiders.
A number of institutional investors have recently bought and sold shares of DHR. Zions Bancorporation grew its stake in Danaher by 118.3% during the 3rd quarter. Zions Bancorporation now owns 1,231 shares of the conglomerate’s stock valued at $106,000 after purchasing an additional 667 shares during the last quarter. Patten Group Inc. grew its stake in Danaher by 262.3% during the 3rd quarter. Patten Group Inc. now owns 4,830 shares of the conglomerate’s stock valued at $114,000 after purchasing an additional 3,497 shares during the last quarter. First Personal Financial Services grew its stake in Danaher by 128.9% during the 4th quarter. First Personal Financial Services now owns 1,227 shares of the conglomerate’s stock valued at $114,000 after purchasing an additional 691 shares during the last quarter. Calton & Associates Inc. purchased a new stake in Danaher during the 4th quarter valued at about $114,000. Finally, CNB Bank purchased a new stake in shares of Danaher in the fourth quarter worth about $116,000. Institutional investors and hedge funds own 77.05% of the company’s stock.
Shares of Danaher (NYSE:DHR) traded up $1.97 during midday trading on Friday, reaching $99.33. The company’s stock had a trading volume of 1,646,735 shares, compared to its average volume of 2,780,000. The company has a current ratio of 1.43, a quick ratio of 1.05 and a debt-to-equity ratio of 0.39. The company has a market cap of $69,290.00, a price-to-earnings ratio of 28.38, a PEG ratio of 2.05 and a beta of 1.04. Danaher has a 1-year low of $78.97 and a 1-year high of $104.82.
Danaher (NYSE:DHR) last issued its earnings results on Tuesday, January 30th. The conglomerate reported $1.19 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.16 by $0.03. The business had revenue of $5.09 billion during the quarter, compared to analyst estimates of $4.97 billion. Danaher had a return on equity of 11.36% and a net margin of 13.60%. Danaher’s revenue was up 10.9% on a year-over-year basis. During the same period in the previous year, the company posted $1.05 EPS. equities research analysts anticipate that Danaher will post 4.37 earnings per share for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, April 27th. Investors of record on Thursday, March 29th will be paid a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a yield of 0.64%. This is an increase from Danaher’s previous quarterly dividend of $0.14. The ex-dividend date is Wednesday, March 28th. Danaher’s payout ratio is 16.00%.
TRADEMARK VIOLATION WARNING: “Danaher Co. (DHR) Receives Average Rating of “Buy” from Brokerages” was originally published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this news story on another domain, it was illegally copied and republished in violation of U.S. and international copyright & trademark laws. The legal version of this news story can be accessed at https://www.dispatchtribunal.com/2018/02/24/danaher-co-dhr-receives-average-rating-of-buy-from-brokerages.html.
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.